160212 - Cardiology Update 6 (in a series of 6) - Dyslipidaemia
This update has been developed with a GP focus in order to expand the understanding of diagnostic and management strategies for patients presenting with dyslipidaemia. A specialist cardiologist will review and examine evidence, patient case studies and the available diagnostic and the treatment options available to General Practitioners.Relevance to General Practice
Cardiovascular disease resulting from atherosclerosis of the arterial vessel wall and thrombosis, is the leading cause of premature mortality and disability adjusted life years, in developed countries. The main clinical entities are coronary artery disease, ischaemic stroke, and peripheral vascular disease. Whilst the causes are multifactorial, dyslipidaemia is a common risk factor and represents an important target in cardiovascular disease prevention and treatment.
Dyslipidaemias cover a broad spectrum of lipid abnormalities and may relate to genetic predisposition, co-morbidities and/or lifestyle factors. In patients with dyslipidaemia, both the indication for treatment and the desired treatment target vary depending on the patient's individual cardiovascular risk.